microbial signature exists in a large prospective cohort of subjects amniotic fluid obtained during amniocentesis during early-to-mid second trimester. STUDY DESIGN: As part of a feasibility study we performed targeted amplicon analysis of the V4 region of the 16S rRNA gene on amniotic fluid collected from gravidae at the time of genetic amniocentesis (gestational ages 16-22wks; feasibility n¼95, total cohort n¼731). Microbial DNA was extracted from samples and negative controls (processed in parallel or archival, n¼32), and submitted for Illumina MiSeq high-throughput sequencing. Sequences were processed with DADA2 to generate an amplicon sequence variant (ASV) table that contains highly resolved taxonomic classifications of microbes. Prevalence-based filtering of putative DNA contaminant sequences using decontam was performed. RESULTS: We initially identified 439 genera present in amniotic fluid. Multidimensional scaling (Bray-Curtis) revealed amniotic fluid samples to discretely separate from negative controls (PERMA-NOVA, p<0.001) (Fig 1A) . Using prevalence-based filtering we identified up to 44 genera that represent putative contaminants. Removal of contaminant ASVs resulted in minimal alterations in the abundance of the top twenty-five most abundant taxa or overall microbial community structure ( Fig 1B) . Post-filtering, when compared to DNA extraction kit negatives, ten of the twenty-five most abundant taxa were classified as indicator taxa (p<0.05) including Staphylococcus, Streptococcus, Lactobacillus, and Bifidobacterium spp. (Fig 1C) . Differential abundance testing revealed 9 ASVs that were significantly enriched based on gestational timepoint at which the fetal urine begins contributing to the amniotic fluid (Fig 1D) . CONCLUSION: Amniotic fluid contains quantifiable levels of microbial DNA and clusters separately from negative controls. Furthermore, we identified highly prevalent ASVs belonging to biologically relevant taxa implicated as important in the postnatal gut health of the newborn, including Lactobacillus and Bifidobacterium spp. OBJECTIVE: Despite being in an environment absent of light-dark signals, under maternal influence the fetus establishes and then maintains its circadian rhythms. Previously, we have demonstrated that this occurs largely in the fetal liver and not in the fetal brain. Moreover, it is under the influence of the maternal diet with a high fat maternal diet being disruptive. In order to understand the precise mechanisms with which this occurs, we generated two novel Npas2 cKO mouse models of the peripheral circadian clock (liver) with loss of Npas2 occurring at distinctive developmental time points (fetal and neonatal) and have shown that Npas2 cKO mice gain significantly more weight (fetal and neonatal) and alter their glucose tolerance (fetal) when compared with controls (wildtype; WT). In this study we aimed to test the hypothesis that loss of hepatic Npas2 and the developmental timing of the loss significantly alters the gene expression of the remaining core circadian clock genes. STUDY DESIGN: Neonatal Npas2 cKO (n¼120) and control mice (WT, n¼132) fed a control diet (CD), neonatal Npas2 cKO (n¼82) and control mice (WT, n¼76) fed a high-fat diet (HFD), and fetal Npas2 cKO (n¼121) and control mice (WT, n¼111) fed a high-fat diet (HFD) were generated for this study. At 16 weeks postweaning mice were euthanized at 4-hour intervals over a 24-hour period (11AM, 3PM, 7PM, 11PM, 3AM, 7AM, 11AM). RNA was extracted from mouse livers and converted to cDNA for qPCR analysis. Taqman probes for circadian genes Bmal1, Clock, Cry1, Cry2, Per1 and Per2 were used to determine relative abundance of these genes. RESULTS: qPCR analysis reveals that neonatal Npas2 cKO mice fed a CD gene expression is unaltered for all circadian genes tested in the liver compared to WT (Figure 1) . CONCLUSION: We have deleted a circadian gene in the liver during fetal development or neonatal life which results in additional weight gain under metabolic stress (HFD), but does not generally disrupt the circadian machinery. Taken together, our findings collectively suggest that disruptions to Npas2 hepatic expression during fetal development result in lifelong metabolic disease risk.
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